References

• 1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
• 2002Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population642 cited
• 2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
• 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
• 2010Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing287 cited
• 2000Trends in Incidence and Prevalence of Major Transfusion-Transmissible Viral Infections in US Blood Donors, 1991 to 1996287 cited
• 2007Transfusion-transmitted infections264 cited
• 2009Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion221 cited
• 2009The risk of transfusion‐transmitted infections in sub‐Saharan Africa160 cited
• 2010Hepatitis B, hepatitis C and HIV transfusion‐transmitted infections in the 21st century144 cited
• 2003Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.126 cited
• 2012Expert Consensus Statement on achieving self‐sufficiency in safe blood and blood products, based on voluntary non‐remunerated blood donation (VNRBD)*125 cited